Green Plains Inc.
GPRE Nasdaq Industrial Organic Chemicals Financials FY2016βFY2025
Last close Β· Oct 23, 2026
$13.98
0.5%What Green Plains Inc. does
No business description yet.
- Legal name
- Green Plains Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 10, 2026
- Accession Β· CIK
- 0001309402-26-000019
0001309402
Revenue and margins
Green Plains Inc. had $2.1B of revenue in fiscal 2025, down 14.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $73.7M in fiscal 2025, 3.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Green Plains Inc. returned $30.7M to shareholders in fiscal 2025, 42% of free cash flow. The diluted share count rose 5.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Green Plains Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $551M | $445M | $350M | $173M | $182M |
| Debt incl. finance leases | $732M | $641M | $605M | $579M | $408M |
| Net debt / EBITDA | 1.5x | β | 7.0x | 9.4x | 7.2x |
| Debt / equity | 0.8x | 0.7x | 0.7x | 0.7x | 0.5x |
| Interest coverage | 0.4x | β3.0x | β1.6x | β1.4x | β0.9x |
| Current ratio | 2.4x | 1.9x | 1.9x | 1.5x | 1.9x |
| Quick ratio | 2.4x | 1.9x | 1.9x | 1.5x | 1.9x |
| Total assets | $2.2B | $2.1B | $1.9B | $1.8B | $1.6B |
| Total liabilities | $1.1B | $1.1B | $949M | $908M | $813M |
| Shareholders' equity | $951M | $910M | $844M | $865M | $766M |
| Net debt (β = net cash) | $181M | $197M | $255M | $406M | $226M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 8 | 7 / 8 | 3 / 8 | 6 / 8 | 7 / 9 | 4 / 9 | 4 / 9 | 3 / 9 | 5 / 9 |
| Accruals ratio | β3.6% | 9.2% | β0.9% | β8.0% | β12.7% | β3.8% | β9.2% | β7.4% | β2.8% | β13.8% |
| Altman Z'' | 2.27 | 1.77 | 2.72 | 1.16 | 1.19 | 2.96 | 1.73 | 1.50 | 0.91 | 0.85 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.4B | $3.3B | $3.0B | $2.4B | $1.9B | $2.8B | $3.7B | $3.3B | $2.5B | $2.1B |
| Gross profit | β | β | β | β | $112M | $202M | $113M | $165M | $130M | $137M |
| Operating income | $91.7M | $23.7M | $90.0M | β$143M | β$123M | $25.5M | β$98.9M | β$61.6M | β$47.5M | β$67.2M |
| Interest expense | $51.9M | $83.7M | $87.4M | $40.2M | $40.0M | $67.1M | $32.6M | $37.7M | $33.1M | $76.7M |
| Pretax income | $38.4M | β$43.2M | $20.0M | β$173M | β$161M | β$43.0M | β$98.7M | β$82.3M | β$71.3M | β$144M |
| Income tax | $7.9M | β$132M | β$20.1M | β$21.3M | β$50.4M | $1.8M | $4.7M | β$5.6M | $6.2M | β$51.7M |
| Net income | $10.7M | $61.1M | $15.9M | β$167M | β$109M | β$66.0M | β$127M | β$93.4M | β$82.5M | β$121M |
| Diluted EPS | $0.28 | $1.47 | $0.39 | β$4.38 | β$3.14 | β$1.41 | β$2.29 | β$1.59 | β$1.29 | β$1.80 |
| Diluted shares | 0.04B | 0.05B | 0.04B | 0.04B | 0.03B | 0.05B | 0.06B | 0.06B | 0.06B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $101M | β$182M | $39.0M | β$9.5M | $98.9M | $4.2M | $69.7M | $56.3M | β$30.0M | $111M |
| Capital expenditure | $58.1M | $44.6M | $40.5M | $75.5M | $111M | $187M | $212M | $108M | $95.1M | $37.2M |
| Free cash flow | $42.6M | β$227M | β$1.6M | β$85.0M | β$11.7M | β$183M | β$143M | β$51.7M | β$125M | $73.7M |
| Depreciation and amortization | $84.2M | $104M | $98.3M | $72.1M | $78.2M | $92.0M | $92.7M | $98.2M | $90.6M | $98.4M |
| Stock-based compensation | $9.5M | $12.2M | $11.4M | $9.7M | $7.9M | $6.1M | $9.1M | $13.0M | $8.3M | $17.1M |
| Acquisitions | $508M | $61.7M | $124M | β | $21.3M | $0.0M | $0.0M | β | β | β |
| Share buybacks | $6.0M | $6.7M | $3.0M | $61.6M | $11.5M | $0.0M | $0.0M | $0.0M | $0.0M | $30.0M |
| Dividends paid | $37.3M | $39.4M | $41.3M | $31.7M | $9.7M | $9.3M | $22.6M | $22.7M | $5.2M | $0.7M |
| Dividends and buybacks | $43.3M | $46.1M | $44.2M | $93.3M | $21.2M | $9.3M | $22.6M | $22.7M | $5.2M | $30.7M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $304M | $267M | $252M | $246M | $234M | $551M | $445M | $350M | $173M | $182M |
| Total debt | $1.1B | $1.4B | $520M | $621M | $572M | $732M | $641M | $605M | $579M | $408M |
| Current assets | $1.0B | $1.2B | $1.2B | $668M | $642M | $1.1B | $929M | $733M | $569M | $523M |
| Current liabilities | $595M | $886M | $834M | $542M | $453M | $472M | $487M | $385M | $386M | $269M |
| Property and equipment, net | $1.2B | $1.2B | $815M | $827M | $802M | $894M | $1.0B | $1.0B | $1.0B | $957M |
| Goodwill | $184M | $183M | $34.7M | $34.7M | $10.6M | $29.1M | $29.1M | β | β | β |
| Intangible assets | β | β | β | β | β | $22.8M | $18.0M | $15.1M | $12.7M | $10.5M |
| Total assets | $2.5B | $2.8B | $2.2B | $1.7B | $1.6B | $2.2B | $2.1B | $1.9B | $1.8B | $1.6B |
| Total liabilities | $1.5B | $1.7B | $1.2B | $833M | $802M | $1.1B | $1.1B | $949M | $908M | $813M |
| Shareholders' equity | $863M | $942M | $947M | $752M | $647M | $951M | $910M | $844M | $865M | $766M |
| Margins | ||||||||||
| Gross margin | β | β | β | β | 5.8% | 7.1% | 3.1% | 5.0% | 5.3% | 6.5% |
| Operating margin | 2.7% | 0.7% | 3.0% | β5.9% | β6.4% | 0.9% | β2.7% | β1.9% | β1.9% | β3.2% |
| EBITDA margin | 5.2% | 3.9% | 6.3% | β2.9% | β2.3% | 4.2% | β0.2% | 1.1% | 1.8% | 1.5% |
| Net margin | 0.3% | 1.9% | 0.5% | β6.9% | β5.7% | β2.3% | β3.5% | β2.8% | β3.4% | β5.8% |
| FCF margin | 1.2% | β6.9% | β0.1% | β3.5% | β0.6% | β6.5% | β3.9% | β1.6% | β5.1% | 3.5% |
| Returns | ||||||||||
| Return on capital | 4.4% | 0.9% | 7.4% | β10.0% | β9.8% | 1.8% | β7.1% | β4.4% | β3.0% | β5.4% |
| Return on capital employed | 4.8% | 1.3% | 6.5% | β12.3% | β10.9% | 1.5% | β6.0% | β4.0% | β3.4% | β5.1% |
| Return on equity | 1.2% | 6.8% | 1.7% | β19.6% | β15.6% | β8.3% | β13.7% | β10.6% | β9.7% | β14.9% |
| Return on assets | 0.4% | 2.3% | 0.6% | β8.5% | β6.6% | β3.5% | β5.9% | β4.6% | β4.4% | β7.2% |
| Return on tangible equity | 1.6% | 8.0% | 1.7% | β23.3% | β17.1% | β7.3% | β14.7% | β11.3% | β9.7% | β16.0% |
| Growth | ||||||||||
| Revenue growth | β | β3.6% | β9.3% | β19.0% | β20.4% | 47.0% | 29.6% | β10.0% | β25.4% | β14.9% |
| Net income growth | β | 472.6% | β73.9% | β1,147.9% | β | β | β | β | β | β |
| EPS growth | β | 425.0% | β73.5% | β1,223.1% | β | β | β | β | β | β |
| FCF growth | β | β632.4% | β | β | β | β | β | β | β | β |
| Share count change | β | 30.2% | β17.9% | β7.6% | β9.1% | 34.7% | 19.1% | 5.9% | 8.5% | 5.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.6x | 8.7x | 1.4x | β | β | 1.5x | β | 7.0x | 9.4x | 7.2x |
| Debt / equity | 1.3x | 1.5x | 0.5x | 0.8x | 0.9x | 0.8x | 0.7x | 0.7x | 0.7x | 0.5x |
| Interest coverage | 1.8x | 0.3x | 1.0x | β3.5x | β3.1x | 0.4x | β3.0x | β1.6x | β1.4x | β0.9x |
| Current ratio | 1.7x | 1.4x | 1.4x | 1.2x | 1.4x | 2.4x | 1.9x | 1.9x | 1.5x | 1.9x |
| Quick ratio | 1.7x | 1.4x | 1.4x | 1.2x | 1.4x | 2.4x | 1.9x | 1.9x | 1.5x | 1.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 1.4% | 1.4% | 3.1% | 5.7% | 6.6% | 5.8% | 3.3% | 3.9% | 1.8% |
| Stock comp / revenue | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.2% | 0.2% | 0.4% | 0.3% | 0.8% |
| Payouts / FCF | 101.6% | β | β | β | β | β | β | β | β | 41.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | 7.0 | 3.0 | 6.0 | 7.0 | 4.0 | 4.0 | 3.0 | 5.0 |
| Altman Z'' | 2.3 | 1.8 | 2.7 | 1.2 | 1.2 | 3.0 | 1.7 | 1.5 | 0.9 | 0.9 |
| Accruals ratio | β3.6% | 9.2% | β0.9% | β8.0% | β12.7% | β3.8% | β9.2% | β7.4% | β2.8% | β13.8% |
Source: SEC EDGAR XBRL filings (CIK 0001309402). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.